Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Income from Non-Controlling Interests (2016 - 2018)

Lifecore Biomedical, Inc. \De\ has reported Income from Non-Controlling Interests over the past 9 years, most recently at $4000.0 for Q2 2018.

  • For Q2 2018, Income from Non-Controlling Interests fell 66.67% year-over-year to $4000.0; the TTM value through May 2019 reached $2000.0, down 97.87%, while the annual FY2018 figure was $94000.0, 8.05% up from the prior year.
  • Income from Non-Controlling Interests for Q2 2018 was $4000.0 at Lifecore Biomedical, Inc. \De\, up from -$2000.0 in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $74000.0 in Q2 2014 and troughed at -$6000.0 in Q1 2017.
  • A 5-year average of $36166.7 and a median of $32000.0 in 2015 define the central range for Income from Non-Controlling Interests.
  • Biggest five-year swings in Income from Non-Controlling Interests: surged 633.33% in 2014 and later plummeted 126.09% in 2017.
  • Year by year, Income from Non-Controlling Interests stood at $24000.0 in 2014, then soared by 150.0% to $60000.0 in 2015, then fell by 20.0% to $48000.0 in 2016, then tumbled by 45.83% to $26000.0 in 2017, then plummeted by 84.62% to $4000.0 in 2018.
  • Business Quant data shows Income from Non-Controlling Interests for LFCR at $4000.0 in Q2 2018, -$2000.0 in Q1 2018, and $26000.0 in Q4 2017.